Description

MAHAMAYA LIFESCIENCES LIMITED equity shares will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective December 1, 2025.

Summary

BSE has announced that equity shares of MAHAMAYA LIFESCIENCES LIMITED (Scrip Code: 544611), an SME IPO listing, will be transferred from the Trade for Trade segment (MT Group) to the Rolling segment effective December 1, 2025. Following this transfer, the company’s shares will be shifted to M Group for trading purposes.

Key Points

  • Company: MAHAMAYA LIFESCIENCES LIMITED (SME IPO)
  • Scrip Code: 544611
  • Current Segment: Trade for Trade segment (MT Group)
  • New Segment: Rolling segment (M Group)
  • Effective Date: December 1, 2025
  • Notice references previous Exchange Notice No. 20251117-58 dated November 17, 2025
  • Contact: Mr. Anurag Jain, Tel: 022-2272 8822

Regulatory Changes

The trading mechanism for MAHAMAYA LIFESCIENCES LIMITED shares is being upgraded from the more restrictive Trade for Trade segment to the Rolling settlement segment. This change allows for intraday trading and normal market operations instead of the delivery-based only trading required in the T2T segment.

Compliance Requirements

Trading members should:

  • Update their systems to reflect the group change from MT to M Group
  • Adjust trading strategies to accommodate rolling settlement instead of trade-for-trade
  • Contact Mr. Anurag Jain for any clarifications or technical details
  • Review the listing notice available on BSE website for complete information

Important Dates

  • November 17, 2025: Previous notice issued (Notice No. 20251117-58)
  • November 18, 2025: Current circular issued
  • December 1, 2025: Effective date for segment transfer from MT Group to M Group

Impact Assessment

This change represents a positive development for MAHAMAYA LIFESCIENCES LIMITED as it moves from the restrictive Trade for Trade segment to normal Rolling settlement. The transfer to M Group will:

  • Improve liquidity by allowing intraday trading
  • Enable normal market mechanisms including margin trading
  • Reduce trading restrictions previously imposed under MT Group
  • Signal completion of initial post-IPO monitoring period
  • Potentially attract more retail and institutional participation due to easier trading mechanisms

The impact is positive for shareholders and traders as it normalizes trading operations for this SME stock.

Impact Justification

Group change affects trading mechanism for MAHAMAYA LIFESCIENCES shares, moving from restrictive Trade for Trade to normal Rolling segment, improving liquidity but with moderate market impact limited to single SME stock